Expression profile of the α subunit of the heterotrimeric G protein in rice

Previous studies on the activity of the rice Gα promoter using a β-Glucuronidase (GUS) reporter construct indicated that Gα expression was highest in developing organs and changed in a developmental stage-dependent manner. In this paper, GUS activity derived from the rice Gα promoter was analyzed in seeds and developing leaves. In seeds, GUS activity was detected in the aleurone layer, embryo, endosperm and scutellar epithelium. In developing leaves, the activity was detected in the mesophyll tissues, phloem and xylem of the leaf sheath and in the mesophyll tissue of the leaf blade. The activity in the aleurone layer and scutellar epithelium suggests that the Gα subunit may be involved in gibberellin signaling. The activity in the mesophyll tissues of the leaf blade suggests that the Gα subunit may be related to the intensity of disease resistance. The pattern of the activity in the developing leaf also indicates that the expression of Gα follows a developmental profile at the tissue level.Key words: expression pattern, Gα subunit, GUS staining pattern, heterotrimeric G protein, riceThe rice mutant d1 is deficient in the heterotrimeric G protein α subunit (Gα). Recently it was found that the dwarfism phenotype of d1 is due to a reduction in cell numbers.¹ This discovery has led to new questions regarding how rice Gα regulates cell number, and which other signaling molecules are involved in this process in various tissues and at different development stages. Studies of d1 suggest that rice Gα participates in both gibberellin signaling^2–4 and brassinosteroid signaling.^5–8 Promoter studies using the β-Glucuronidase (GUS) reporter indicate that Gα expression is highest in developing organs.¹ In this paper, we report on the expression pattern of a Gα promoter::GUS construct in seeds and developing leaves of rice.     

Cross-linking of F508-CFTR promotes its trafficking to the plasma membrane

CFTR is a cAMP-activated chloride channel responsible for agonist stimulated chloride and fluid transport across epithelial surfaces.¹ Mutations in the CFTR gene lead to cystic fibrosis (CF) which affects the function of secretory organs like the intestine, the pancreas, the airways and the sweat glands. Most of the morbidity and mortality in CF has been linked to a decrease in airway function.² The ΔF508 mutation is the most common CF-related mutation in the Caucasian population and represents 90% of CF alleles. Homozygote carriers of this mutation present with a severe CF phenotype.³ The ΔF508 mutation causes misfolding of the nascent CFTR polypeptide, which leads to inefficient export from the endoplasmic reticulum (ER) and rapid degradation by the proteasome.⁴Key words: cystic fibrosis, endoplasmic reticulum, oligomer, processing mutation, curcuminGiven the frequency of the ΔF508 processing mutation and the severity of its corresponding phenotype, much research has focused on identifying compounds that restore the trafficking and function of this mutant at the plasma membrane. Several synthetic ‘correctors’ of ΔF508 mis-processing and ‘potentiators’ of mutant channel activity have been identified.^5,6 Natural compounds such as curcumin also have generated interest. Curcumin is an organic phenolic compound abundant in turmeric, an Indian spice extracted from the rhizome of Curcuma longa.⁷ Earlier studies performed using ΔF508/ΔF508 mouse models and human airway epithelial cell lines suggested that curcumin may act as a ΔF508-CFTR trafficking corrector.⁸ Also, we and others showed that curcumin stimulates CFTR channel activity in excised membrane patches.^9,10 This stimulation occurs in the absence of ATP binding, which is normally required for channel opening.¹⁰ Binding sites of correctors and potentiators within the CFTR polypeptide as well as the molecular mechanisms underlying the rescue of CFTR trafficking and function remain to be elucidated. In our attempt to understand how curcumin could circumvent the normally critical step of ATP binding to promote CFTR channel activity we investigated the effect of curcumin on CFTR conformation by using biochemical assays. We showed that curcumin caused dimerization of several CFTR channel constructs (including ΔF508-CFTR) in a dose- and time-dependent manner both in microsomes and within intact cells. This effect of curcumin on CFTR oligomerization is attributable to its reactive β-diketone groups, which may undergo an oxidation reaction with CFTR nucleophilic amino acid residues.¹¹ Importantly, CFTR channel activation by curcumin is unrelated to its cross-linking effect. We identified cyclic derivatives of curcumin that lack this cross-linking activity but still promote CFTR channel function.¹¹Here we examined the possibility that the cross-linking of ΔF508-CFTR channels by curcumin promotes the delivery of this ER processing mutant to the cell surface. We were motivated to test this possibility for three reasons: (i) our previous evidence that curcumin-induced dimers of wild-type CFTR polypeptides were detected at the cell surface where they remained over an hour after the removal of curcumin;¹¹ (ii) the very efficient cross-linking of the immature (ER) forms of wild-type CFTR and the ΔF508-CFTR mutant that we observed earlier¹¹ and (iii) prior evidence from our group that the ER export and cell surface delivery of ΔF508-CFTR polypeptides could be promoted by the co-expression of this mutant with certain CFTR fragments (trans-complementation).¹² The latter result might be due to the existence of ER retention ‘signals’ that are exposed on the ΔF508-CFTR polypeptide but become buried by interacting (complementing) fragments.Figure 1 provides evidence that ΔF508-CFTR oligomers that form in response to curcumin treatment do indeed appear at the surfaces of cultured airway epithelial cells (CF bronchial epithelial (CFBE) cells stably transfected with this CFTR mutant). Surface biotinylation assays were performed to detect the appearance of ΔF508-CFTR polypeptides at the cell surface. MESNA, a cell impermeant reducing agent that cleaves the biotin label, was used to verify the surface accessibility of the labeled ΔF508-CFTR polypeptides. ΔF508-CFTR polypeptides were precipititated with streptavidinagarose (surface pool) or with a CFTR monoclonal antibody (total pool). In the absence of curcumin treatment the great majority of the ΔF508-CFTR protein existed as the ER form (monomeric band B), as previously observed by many investigators (Fig. 1, lane 5). No band B was detected in the surface pool before or after curcumin treatment (Fig. 1, lanes 1, 2). As we reported earlier, treatment of the cells with 50 µM curcumin for 15 mins at 37°C cross-linked nearly all of the ΔF508-CFTR polypeptides into higher order complexes (e.g., dimers, termed band D here; lanes 6–8 in Fig. 1). Interestingly, these higher order forms of ΔF508-CFTR were readily apparent in the surface pool (Fig. 1, lane 2).Open in a separate windowFigure 1ΔF508-CFTR oligomers detected at the surfaces of airway epithelial cells after curcumin treatment. ΔF508-CFTR expressing CFBE cells were treated with curcumin (50 µM) for 15 min at 37°C. Cell surface proteins were then biotinylated (Sulfo-NHS-SS-Biotin, 1 mg/ml) for 30 min at 4°C followed by cell lysis with 1% Triton X-100. Surface proteins were isolated by streptavidin pulldown and ΔF508-CFTR was isolated from the total cell protein pool by immunoprecipitation with an anti-CFTR C-terminus antibody (clone 24-1, R&D systems). After SDS-PAGE the ΔF508-CFTR signal was detected by immunoblotting using the 24-1 antibody described above. (SP: streptavidin pulldown; IP: immunoprecipitation). As an additional control curcumin-treated cells were treated with the cell impermeant MESNA after biotinylation to strip the biotin off the cell surface proteins with which it had reacted.CFTR oligomers also can be generated by standard chemical cross-linkers such as DSS, as previously reported by others and confirmed by us.¹³ Figure 2 shows that oligomers of ΔF508-CFTR that are induced by DSS treatment also appear in the surface pool. These experiments were performed using transiently transfected HEK-293T cells with 30 µM curcumin as a positive control. Quantitative densitometry results are shown in Figure 3. By titrating the DSS concentration we observed a dose-dependent disappearance of the monomeric band B form, a corresponding increase in the band D (dimer) pool and the appearance of higher order oligomers (band E) which prevailed at higher DSS concentrations (see total cell pool data in right-hand). A small amount of the band D form was detected in the absence of DSS or curcumin treatment, which might represent some spontaneous cross-linking of ΔF508-CFTR polypeptides under these conditions. The DSS and curcumin-induced ΔF508-CFTR oligomers were readily detected in the surface pool. The densitometry analysis revealed that 20 ± 5% and 33 ± 19% of the total oligomer pool (combined bands D and E) was found in the surface pool after treatment with 0.1 mM DSS (n = 3) or 30 µM curcumin (n = 3), respectively, which corresponded to a 17 ± 7 and 26 ± 20 fold increase compared to the control condition (i.e., no DSS or no curcumin).Open in a separate windowFigure 2ΔF508-CFTR oligomers detected at the surfaces of HEK cells after DSS or curcumin treatment. ΔF508-CFTR expressing HEK cells were treated with the indicated concentrations of DSS or with 30 µM curcumin (*) for 15 min at 37°C. Cell surface proteins were then biotinylated and isolated by streptavidin pulldown as described above. ΔF508-CFTR was immunoprecipitated from the total cell protein pool with the 24-1 antibody and detected by immunoblotting as before (SP: streptavidin pulldown; IP: immunoprecipitation). Band B corresponds to ΔF508 monomer (ER form). Band D corresponds to ΔF508 dimer. Band E corresponds to a higher degree of ΔF508 oligomerization. Each panel corresponds to a different exposure of the same blot.Open in a separate windowFigure 3Dose-dependent expression of ΔF508-CFTR oligomers at the surfaces of HEK cells after DSS treatment. CFTR signals detected by the 24-1 antibody from three different experiments as the one described in Figure 2 were analyzed using the ImageJ software (from the National Institute of Health). (A) band B signal intensity is plotted as a function of the DSS concentrations. Signals analyzed correspond to ΔF508-CFTR band B immunoprecipitated by the 24-1 antibody. (B) band D plus band E signal intensities are plotted as a function of the DSS concentration. Signals analyzed correspond to the sum of ΔF508-CFTR band D and band E immunoprecipitated by the 24-1 antibody. (C) band D plus band E signal intensities at the cell surface are plotted as a function of the DSS concentration. Signals analyzed correspond to the sum of ΔF508-CFTR band D and band E isolated from the surfaces of ΔF508-CFTR expressing HEK cells by biotinylation and streptavidin pulldown. (D) the ratio between the amount of band E and D at the surfaces of ΔF508-CFTR expressing HEK cells is plotted as a function of the DSS concentration. Error bars are SEMs.Altogether these data indicate that the cross-linking of ΔF508-CFTR band B into oligomers by curcumin or DSS allows ΔF508-CFTR to traffic to the cell surface. This effect might be caused by the burial of ER retention motifs within the oligomer, which also could explain our previous trans-complementation results in which we observed that certain CFTR fragments promote the cell surface delivery of this processing mutant.¹² Although non-specific protein cross-linkers like DSS would not be therapeutically beneficial, more specific CFTR cross-linkers (perhaps curcumin?) may be worth considering for treating CF disease linked to ER processing mutations in CFTR. In this regard, we note that cross-linked CFTR polypeptides appear to retain chloride channel activity. Namely, in our prior excised patch clamp studies we observed stable CFTR channel activity when these patches were exposed to curcumin at doses and times that promote robust cross-linking of CFTR polypeptides.^10,11     

Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways

Evidence that protein phosphatase 2A (PP2A) is a tumor suppressor in humans came from the discovery of mutations in the genes encoding the Aα and Aβ subunits of the PP2A trimeric holoenzymes, Aα-B-C and Aβ-B-C. One point mutation, Aα-E64D, was found in a human lung carcinoma. It renders Aα specifically defective in binding regulatory B′ subunits. Recently, we reported a knock-in mouse expressing Aα-E64D and an Aα knockout mouse. The mutant mice showed a 50–60% increase in the incidence of lung cancer induced by benzopyrene. Importantly, PP2A''s tumor suppressor activity depended on p53. These data provide the first direct evidence that PP2A is a tumor suppressor in mice. In addition, they suggest that PP2A is a tumor suppressor in humans. Here, we report that PP2A functions as a tumor suppressor in mice that develop lung cancer triggered by oncogenic K-ras. We discuss whether PP2A may function as a tumor suppressor in diverse tissues, with emphasis on endometrial and ovarian carcinomas, in which Aα mutations were detected at a high frequency. We propose suitable mouse models for examining whether PP2A functions as tumor suppressor in major growth-stimulatory signaling pathways, and we discuss the prospect of using the PP2A activator FTY720 as a drug against malignancies that are driven by these pathways.Key words: lung cancer, oncogenic K-ras, p53, Aα mutations in endometrial cancerUnderstanding how protein phosphatase 2A (PP2A) functions as a tumor suppressor requires knowledge of its complex structure and the roles its numerous regulatory subunits play. The trimeric holoenzyme is composed of a catalytic C subunit, a scaffolding A subunit and one of many regulatory B subunits. The catalytic C subunit exists as two isoforms, Cα and Cβ, that are 96% identical. The scaffolding A subunit also exists as two isoforms, Aα and Aβ, and they are 87% identical. The B subunits fall into four families designated B, B′, B″ and B‴. The B or PR55 family has four members; the B'' family (also designated B56 or PR61) consists of five isoforms and additional splice variants, and the B” or PR72 family has four members including splice variants. B, B′ and B″ are largely unrelated by sequence. The combination of all subunits could give rise to over 70 distinct holoenzymes. In addition, the ability of PP2A to associate with approximately 150 other proteins further increases its regulatory potential.^1–5 Figure 1B shows a schematic diagram of the holoenzyme whose subunit interactions and structure have been revealed initially by biochemical studies^17,18 and subsequently in great detail by crystal structure analyses.^19–23 Through this work and numerous other investigations, it has become increasingly clear over the past 25 years that PP2A is not just a nonspecific phosphatase, as it was thought to be initially, but a highly sophisticated enzyme involved in most, if not all, fundamental cellular processes. One of the most challenging properties of PP2A is its role as a tumor suppressor, which has been covered by excellent reviews in references ^24–28. The present report highlights recently developed mouse models for investigating PP2A''s tumor suppressor activity.Open in a separate windowFigure 1Model of PP2A holoenzyme; location of human cancer-associated Aα mutations; high frequency of Aα mutations in endometrial cancer. (B) Trimeric PP2A holoenzyme consists of one catalytic subunit (Cα or Cβ), one scaffolding subunit (Aα or Aβ) and one of several regulatory subunits (B, B'' or B”). Aα and Aβ consist of 15 repeats connected by inter-repeat loops. Each repeat consists of two antiparallel α-helices connected by intra-repeat loops. (A) Aα mutations in endometrial (endo) or ovarian (ovary) cancer are clustered at or near intra-repeat loop 5 of repeat 5 (from P179 to R183) and at or near intra-repeat loop 7 of repeat 7 (from R249 to R258). Numbers in parentheses represent number of tumors with a mutation at a particular site.^6–9 E64D, E64G and R418W were found in lung, breast and skin cancer, respectively.¹⁰ Shown in (C and D) are C-terminal truncations, Δ171–589 from breast cancer missing repeats 6 to 15¹⁰ and Δ375–589 from kidney cancer missing repeats 11 to 15.¹¹ (E) Frequency of Aα mutations in endometrial (18%, 31/171) and ovarian (6%, 27/470) cancers in comparison to K-ras, Arf, p53 and PI3K.^6–9 (F) Loss of Bα, B''γ3 (formerly known as B''α1),¹² and B”/PR72 binding to mutant Aα. Note: All Aα mutants are defective in B''γ3 binding.^13,14 For E393Q, see reference ¹⁵; for R183W in pancreatic (pa) cancer, see reference ¹⁶; *indicates synthetic mutant.     

Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant

Growing evidence suggests the Δ133p53α isoform may function as an oncogene. It is overexpressed in many tumors, stimulates pathways involved in tumor progression, and inhibits some activities of wild-type p53, including transactivation and apoptosis. We hypothesized that Δ133p53α would have an even more profound effect on p53 variants with weaker tumor-suppressor capability. We tested this using a mouse model heterozygous for a Δ133p53α-like isoform (Δ122p53) and a p53 mutant with weak tumor-suppressor function (mΔpro). The Δ122p53/mΔpro mice showed a unique survival curve with a wide range of survival times (92–495 days) which was much greater than mΔpro/- mice (range 120–250 days) and mice heterozygous for the Δ122p53 and p53 null alleles (Δ122p53/-, range 78–150 days), suggesting Δ122p53 increased the tumor-suppressor activity of mΔpro. Moreover, some of the mice that survived longest only developed benign tumors. In vitro analyses to investigate why some Δ122p53/mΔpro mice were protected from aggressive tumors revealed that Δ122p53 stabilized mΔpro and prolonged the response to DNA damage. Similar effects of Δ122p53 and Δ133p53α were observed on wild-type of full-length p53, but these did not result in improved biological responses. The data suggest that Δ122p53 (and Δ133p53α) could offer some protection against tumors by enhancing the p53 response to stress.The p53 tumor suppressor is most important for preventing cancers. p53 controls cell fate in response to stress by inducing apoptosis, cell cycle arrest/senescence, DNA repair (reviewed in Braithwaite et al.,^{1, 2} Oren,³ and Speidel⁴) or possibly restricting supply of basic substrates for metabolism.^{5, 6, 7} The regulation of p53 function has recently become more complex with the discovery of 13 isoforms, which may interfere with the normal functioning of full-length (FL) p53.^{8, 9, 10, 11, 12, 13, 14} An alternative promoter in intron 4 generates the Δ133p53 isoforms (Δ133p53α, and with additional alternative splicing in intron 9, Δ133p53β, and Δ133p53γ¹¹).The Δ133p53α isoform is expressed in many tissues, but elevated levels have been found in several cancers.^{11, 15, 16} Although the function(s) of Δ133p53α are not fully understood, growing evidence suggests it may have tumor-promoting capacities. Reducing Δ133p53α levels in the U87MG glioblastoma cell line reduced its ability to migrate and stimulate angiogenesis.¹⁷ Δ133p53α may also interfere with the tumor-suppressor functions of FLp53. The zebrafish ortholog of Δ133p53α, Δ113p53, inhibited p53-mediated apoptosis,¹⁸ and overexpression of Δ133p53α inhibited p53-directed G₁ cell cycle arrest.¹⁶Previously, we reported the construction and characterization of a mouse expressing an N-terminal truncation mutant of p53 (designated Δ122p53) that is very similar to Δ133p53α, providing the first mouse model of the Δ133p53α isoform.^{19, 20} Δ122p53 was found to increase cell proliferation and in p53 null cells transduced with a Δ122p53 expressing retrovirus, inhibited the transactivation of CDKN1a (encoding) p21^CIP1 and MDM2 by FLp53.^{19, 20} As well as elevating cell proliferation, homozygote Δ122p53 mice exhibited a profound pro-inflammatory phenotype, including increased serum interleukin-6 (IL-6) and γ-interferon (γ-IFN), and features of autoimmune disease.^{19, 20} The mice were tumor-prone displaying a complex tumor spectrum, but predominantly B-cell lymphomas and osteosarcomas. Thus, most evidence supports a role for the Δ133p53α isoform as a dominant oncogene that may interfere with normal FLp53 tumor-suppressor functions, but also has additional ''gain-of-function'' properties to promote tumor progression, probably through inflammatory mechanisms.²¹Given the above data, we reasoned that in an environment where p53 tumor-suppression capacity is compromised, such as in the context of the R72P allele^{22, 23, 24} or where p53 levels are reduced,^{25, 26, 27} the influence of Δ133p53α isoform on FLp53 function would be greater, leading to rapid tumor formation with a phenotype that would resemble that of the isoform alone. To test this, we generated mice heterozygous for Δ122p53 and a p53 mutant (mΔpro) that we previously described, that has attenuated tumor-suppressor activity.^{28, 29} The mΔpro mouse model is missing part of the p53 proline rich domain (PRD, amino acids 58–88). These mice are defective for DNA damage-induced apoptosis, and show a delayed and impaired cell cycle arrest response. Homozygous mΔpro mice develop late onset follicular B-cell tumors, while mΔpro heterozygotes developed few tumors in the presence of a wild-type p53 allele, or an early onset T-cell lymphoma in a p53-null background. In the latter case, the onset and tumor spectrum are indistinguishable from p53-null mice.²⁸In the current study, we found that, in contrast to our hypothesis, many Δ122p53/mΔpro mice showed extended survival compared with Δ122p53 homozygotes. In vitro analyses to explain this phenomenon suggested that Δ122p53 allele can enhance mΔpro tumor-suppressor functions, in particular cell cycle arrest.     

Role of AtPol ζ, AtRev1 and AtPolη in γ ray-induced mutagenesis

Although ionizing radiation has been employed as a mutagenic agent in plants, the molecular mechanism(s) of the mutagenesis is poorly understood. AtPolζ, AtRev1 and AtPolη are Arabidopsis translesion synthesis (TLS)-type polymerases involved in UV-induced mutagenesis. To investigate the role of TLS-type DNA polymerases in radiation-induced mutagenesis, we analyzed the mutation frequency in AtPolζ-, AtRev1- or AtPolη-knockout plants rev3-1, rev1-1 and polh-1, respectively. The change in mutation frequency in rev3-1 was negligible, whereas that in rev1-1 decreased markedly and that in polh-1 increased slightly compared to wild-type. Abasic (apurinic/apyrimidinic; AP) sites, induced by radiation or generated during DNA repair processes, can pair with any kind of nucleotide on the opposite strand. 7,8-dihydro-8-oxo-2′-deoxyguanosine (8-oxo-dG), induced by radiation following formation of reactive oxygen species, can pair with cytosine or adenine. Therefore, AtRev1 possibly inserts dC opposite an AP site or 8-oxo-dG, which results in G to T transversions.Key words: ionizing radiation, DNA damage, translesion synthesis, ROS, 8-oxo-dG, ArabidopsisIonizing radiation has been applied to various plants for the purpose of generating useful agricultural resources. A variety of ionizing radiation forms, including X rays, γ rays, neutrons and ion-beams, have been used as mutagens for mutation breeding in addition to chemical mutagens.¹ Nevertheless, the molecular mechanism(s) associated with radiation-induced mutations in higher plants remains to be fully understood.In animals and microorganisms, it is known that a large proportion of mutations occur when damaged DNA is replicated by specific DNA polymerases. This activity is referred to as “translesion synthesis (TLS),” and represents one of the damage-tolerance pathways conserved from bacteria to humans. TLS-type polymerases have a more relaxed active site structure compared to replicases and therefore can act on damaged templates. However, the very flexible nature of the active site can induce high and sometimes fatal, replication errors. In higher plants, the presence of several TLS-type polymerase genes was reported. AtREV3 encodes the catalytic subunit of AtPolζ.² AtPOLK, AtREV1 and AtPOLH encode AtPolκ, AtRev1 and AtPolη, respectively.^3–7 In our previous paper, we suggested the role of three TLS-type polymerases, AtPolζ, AtRev1 and AtPolη, in the formation of UV-induced mutations.⁸Since the variety and ratio of UV-induced DNA damage have been well characterized, and the TLS activity of each polymerase can be examined in vitro, it is relatively easy to speculate on how the TLS polymerases induce mutation following UV-exposure. By contrast, ionizing radiation can induce a variety of damage, including damage to bases and strand breaks, and the role of TLS-type polymerases in radiation-induced mutation is less understood.In an effort to determine whether TLS polymerases are involved in radiation-induced mutation in higher plants, we analyzed the mutation frequency in Arabidopsis somatic tissues following γ ray irradiation. The reporter gene used for this analysis was the uidA_166G-T gene, which contains a nonsense mutation generated by replacement of the 166^th guanine with thymine.⁹ The reporter gene integrated in the Arabidopsis genome will become active when a T-to-G reversion occurs at the 166^ththymine. To detect γ ray-induced mutations, transgenic plants carrying the uidA_166G-T were treated with 100 Gy of γ rays and then grown for another 10 days, so that cells with an active uidA gene can proliferate and produce a detectable blue sector on somatic tissues.To investigate the roles of TLS-type polymerases in radiation-induced mutations, we examined the mutation frequencies in disruptants of the AtREV3, AtREV1 and AtPOLH genes, rev3-1, rev1-1 and polh-1, respectively, and compared these to that of wild-type. The reversion events in rev3-1 did not change significantly compared to wild-type siblings (Fig. 1). This is contrasted with the reduction in UV-induced mutation frequency when AtPolζ is disrupted.⁸ However, the reversion events in rev1-1 plants were less than 1/10 of that in wild-type siblings (p < 0.01). This result indicates that AtRev1 plays a role in promoting γ ray-induced mutations. The reversion event in polh-1 was slightly (∼1.4 times) higher than that in wild-type siblings (p < 0.05), suggesting that AtPolη plays a role in reducing γ ray-induced mutations.Open in a separate windowFigure 1γ ray-induced mutation frequencies in AtREV3-, AtREV1- and AtPOLH-disrupted plants. Wild-type and mutant derived from a single F1 plant were examined concurrently. Bars represent average frequencies per 100 plants derived from multiple experiments. error bars indicate ±SE. *p < 0.01; **p < 0.05.The frequencies in wild-type, rev3-1, rev1-1 and polh-1 were 12, 22, 1.9 and 13 times higher, respectively, with γ ray exposure compared to the spontaneous mutation frequency as previously reported.⁸ These results indicate that the G to T transversion was greatly induced by γ ray exposure.Since ionizing radiation can induce a variety of damage to DNA or nucleotide pools, the mechanisms associated with radiation-induced mutagenesis would be more complicated than those pertaining to UV-induced mutagenesis. It is known that some kinds of damage are more abundantly generated by ionizing radiation. Additionally, some kinds of damage are preferentially used as templates or substrates by specific DNA polymerases. Based on previous reports relating to plants or other organisms, we propose two possible mechanisms to account for the γ ray-induced reversion events (Fig. 2).Open in a separate windowFigure 2Possible role of TLS polymerases in γ ray-induced mutagenesis. (A) role of TLS polymerases in the replication of AP sites. Ionizing radiation induces formation of an AP site (O). AtRev1 inserts dC opposite the AP site, leading to a G to T transversion. AtPolη inserts dA or T opposite the AP site, contributing less to G to T transversions. (B) Ionizing radiation induces the formation of reactive oxygen species (ROS) which oxidize guanine (G) in DNA or dGTP, producing 8-oxo-dG or 8-oxo-dGTP (G^o). 8-oxo-dGTP is misincorporated opposite adenine (A) through replication. G^o is paired with cytosine (C) at the next round of DNA replication, which results in a T to G transversion. AtPolη inserts dC or dA opposite G^o, whereas AtRev1 inserts dC opposite G^o. Other polymerases including AtPolκ might insert dA opposite G^o.Abasic (apurinic/apyrimidinic; AP) sites represent one of the most abundant DNA lesions that occur spontaneously and are induced by radiation.¹⁰ AP sites can also be generated during the DNA repair process.¹¹ If the 166^th T of our marker gene were lost following irradiation with γ rays, the template would induce various mutations.Among the TLS-type polymerases, Rev1s share the specific ability to insert dCMP opposite AP sites.^12–14 Therefore, the significant reduction in mutation frequency in AtRev1-knockout plants might be due to loss of dCMP insertion opposite AP sites (Fig. 2A). In contrast, it was shown that yeast or human Polηs insert dA or T opposite AP sites or AP-site analogs.^15–17 Thus, the activity of Polη does not seem to contribute toward T to G transversions (Fig. 2A). The incidence of mutagenic bypass of AP sites by AtRev1 may be greater when AtPolη is absent, which elevates the mutation frequency slightly.Given the similar reduction in UV-induced mutation frequencies, we previously suggested that AtRev1 cooperates with AtPolζ to bypass UV-damage.⁸ In contrast, no significant change in γ ray-induced mutation frequency was observed in AtPolζ-knockout plants. This suggests that AtRev1 might work independently of AtPolζ when bypassing AP sites, although it is not consistent with previous reports concerning yeast.^15,16Radiation damages cells through the formation of reactive oxygen species (ROS). ROS induce oxidative damage of DNA, including strand breaks and base and nucleotide modifications. The formation of 7,8-dihydro-8-oxo-2′-deoxy-guanosine (8-oxo-dG) represents one of the most abundant and best characterized type of oxidative damage.¹⁸ 8-oxo-dG can pair with cytosine or adenine, inducing frequent base substitutions. In addition to direct oxidation of deoxyguanosine (dG) in DNA, 8-oxo-dG can be generated by the incorporation of oxidized dGTP (8-oxo-dGTP) into DNA during the replication process.¹⁹ 8-oxo-dG in DNA induces mutations when used as a template for the next round of replication. If 8-oxo-dGTP were incorporated in lieu of the 166^thT and paired with dC in the next round of replication, it would lead to a T to G transversion (Fig. 2B).It was shown that yeast and human Rev1s insert dC at positions opposite 8-oxo-dG.^13,20 Therefore, the reduction in mutation frequency in AtRev1-knockout plants could be due to loss of dCMP insertion opposite 8-oxo-dG (Fig. 2B). Although human and yeast Polηs can insert dC or dA opposite 8-oxo-dG, the insertion efficiencies and dC/dA ratios differ depending on the assay conditions and sequence context.^21–25 Thus, the balance of error-free and error-prone bypass activities of Polη might interfere with the mutation frequency in individual assays. The slight increase in mutation frequency in AtPolη-knockout plants suggests that the ratio of dC insertion by other polymerases was slightly higher when AtPolη is absent.In yeast, spontaneous mutations in base excision repair (BER)-deficient cells are not reduced by elimination of Polζ, suggesting a minor role of Polζ in 8-oxo-dG induced mutations.^26,27 Our result demonstrating no reduction in mutation frequency in AtPolζ-knockout plants suggests that AtPolζ is also dispensable in terms of 8-oxo-dG induced mutagenesis. However, the root growth of AtPolζ-knockout plants is severely inhibited by γ ray exposure.^2,4 Therefore, it is possible that AtPolζ has other function(s) in radiation-induced damage responses.In addition to the three polymerases examined in this report, Arabidopsis possesses an additional TLS-type polymerase referred to as AtPolκ. In vitro analysis revealed that AtPolκ preferentially inserts dA opposite 8-oxo-dG,²⁸ as is the case with human Polκ.^29,30 Therefore, it is conceivable that AtPolκ has a function to promote T to G transversions (Fig. 2B). It will be interesting to measure the mutation frequency in AtPolκ-knockout plants following γ ray exposure. Further, analyses of mutation frequencies in BER- or mismatch repair (MMR)-deficient mutants will be necessary to delineate the mechanism(s) of radiation-induced mutagenesis in higher plants.     

Is membrane occupation and recognition nexus domain functional in plant phosphatidylinositol phosphate kinases?

Phosphatidylinositol phosphate kinase (PIPK) catalyzes a key step controlling cellular contents of phosphatidylinositol-4,5-bisphosphate [PtdIns(4,5)P₂], a critical intracellular messenger involved in vesicle trafficking and modulation of actin cytoskeleton and also a substrate of phospholipase C to produce the two intracellular messengers, diacylglycerol and inositol-1,4,5-trisphosphate. In addition to the conserved C-terminal PIPK catalytic domain, plant PIPKs contain a unique structural feature consisting of a repeat of membrane occupation and recognition nexus (MORN) motifs, called the MORN domain, in the N-terminal half. The MORN domain has previously been proposed to regulate plasma membrane localization and phosphatidic acid (PA)-inducible activation. Recently, the importance of the catalytic domain, but not the MORN domain, in these aspects was demonstrated. These conflicting data raise the question about the function of the MORN domain in plant PIPKs. We therefore performed analyses of PpPIPK1 from the moss Physcomitrella patens to elucidate the importance of the MORN domain in the control of enzymatic activity; however, we found no effect on either enzymatic activity or activation by PA. Taken together with our previous findings of lack of function in plasma membrane localization, there is no positive evidence indicating roles of the MORN domain in enzymatic and functional regulations of PpPIPK1. Therefore, further biochemical and reverse genetic analyses are necessary to understand the biological significance of the MORN domain in plant PIPKs.Key words: membrane occupation and recognition nexus (MORN) domain, phosphatidylinositol phosphate kinase, phosphatidic acid, Physcomitrella patensPhosphoinositides (PIs) are minor membrane phospholipds that play pivotal roles in various signal transduction cascades involved in development and stress response via the regulation of cytoskeletal organization, ion channel activation and vesicle trafficking.^1,2 These are derivatives of phosphatidylinositol (PtdIns) produced by phosphorylation of the 3-, 4- and 5- positions of the inositol ring.² To address the roles of PIs, enzymes involved in their production have been extensively studied using biochemical and molecular biological approaches. Of these enzymes, phosphatidylinositol monophosphate kinases (PIPKs) catalyze the reaction producing phosphatidylinositol-4,5-bisphosphate [PtdIns(4,5)P₂] that is a substrate of phospholipase C and phosphatidylinositol 3-kinase, and also acts as an intracellular messenger involved in the regulation of F-actin organization and activity of ion channels.^1–3 Although PtdIns(4,5)P₂ is produced by sequential phosphorylation by phosphatidylinositol 4-kinase, producing phosphatidylinositol-4-phosphate [PtdIns(4)P], and then by PIPK,^1,2 the cellular levels of PtdIns(4)P are much higher compared to PtdIns(4,5)P₂.^4–6 Thus, a restriction step controlling cellular PtdIns(4,5)P₂ contents is mediated by PIPKs, indicating the importance of PIPK regulation in various kinds of physiological processes.The roles of plant PIPKs have been established in growth regulation, such as polarized tip growth of root hairs and pollen tubes, via their localization at plasma membranes.^7–12 It is worth to note that plant PIPKs contain a unique structure consisting of a repeat of a membrane occupation recognition nexus (MORN) motifs, called MORN domain, at the N-terminal region and a C-terminal PIPK catalytic domain, except for AtPIP5K10 and AtPIP5K11 from Arabidopsis thaliana, which lack the N-terminal MORN domain.¹³ The MORN domain was first identified as plasma membrane-binding module in junctophilin¹⁴ and the involvement of the MORN domain in plasma membrane localization was proposed for A. thaliana AtPIP5K1 and AtPIP5K3.^9,15,16Another remarkable feature of eukaryotic PIPKs is dependency of the enzymatic activity on phosphatidic acid (PA).^17,18 Indeed, PA-dependent activation of PIPKs has been observed in A. thaliana and in the moss Physcomitrella patens,^6,19,20 as with animal type I PIPKs.²¹ Although much less is known about how PA activates PIPKs in plants, biochemical analyses suggested the involvement of the MORN domain in PA-dependent activation of AtPIP5K1.¹⁵Based on above findings, it was proposed that plasma membrane-localization and PA-dependent activation of plant PIPKs might be regulated by the MORN domain.^9,15,16 In contrast, we recently demonstrated the critical involvement of the C-terminal half containing the catalytic domain of plant PIPKs in both plasma membrane-localization and PA-dependent activation.²² Thus, the function of the MORN domain remains elusive in plant PIPKs.As shown earlier, the N-terminal half of P. patens PpPIPK1 containing the MORN domain enhances its catalytic activity.²² Thus, to identify the region required for the activation of PpPIPK1, we further dissected the N-terminal half into 3 regions; the N-terminal region (amino acid nos. 1–154), the MORN repeat (amino acid nos. 155–316) and the linker region (amino acid nos. 338–452), and made deletion mutants of PpPIPK1 as shown in Figure 1A. Using Pfu Turbo DNA polymerase (Stratagene, La Jolla, USA), DNA fragments corresponding to deletion mutants lacking the N-terminal and N-terminal plus the MORN repeat, designated PpPIPK1ΔN and PpPIPK1ΔN-MORN, respectively, were amplified with primer sets; one is M_PIPK1_fb (5′-GGC AAG CAC GTG TAT AAT GTC TGA AGG GCT T-3′) and XhoIPIPK1 (5′-TAA ACT CGA GTT AGC TGG GTA GGA GGA AA-3′) and the other is M_PIPK1_f7 (5′-AGA GAA CAC GTG TAT AAT GTC TGA CTT CTA CGT CGG T-3′) and XhoIPIPK1. For building an expression plasmid for a deletion mutant lacking the MORN repeat, designated PpPIPK1ΔMORN, the N-terminal region and PpPIPK1ΔN-MORN were amplified with primer sets, M_PIPK1_fb and M_PIPK1_r3 (5′-TTG TAA GTC TCG GGT GCC ATT TGA GAG CTC-3′) M_PIPK1_f6 (5′-GAG CTC TCA AAT GGC ACC CGA GAC TTA CAA-3′) and XhoIPIPK1, respectively, using Pfu Turbo DNA polymerase and resultant DNA fragments were fused by PCR with a primer set, M_PIPK1_fb and XhoIPIPK1 using the same enzyme. These PCR products were digested with Pml1 and XhoI and inserted into Pml1-XhoI digested pPICZB (Invitrogen) to construct expression plasmids, pPICZB-PpPIPK1ΔN, pPICZB-PpPIPK1ΔN-MORN and pPICZB-PpPIPK1ΔMORN. Transformation of P. pastoris X-33 cells with the above expression plasmids, colony PCR of transformants and following expression, purification and western blot analysis of His-tagged recombinant proteins were performed as described previously.⁶ The PIPK activity assay using purified His-tagged proteins was carried out as described previously²³ with the modifications.⁶Open in a separate windowFigure 1Functional dissection of the N-terminal region of PpPIPK1 identifies positive regulatory regions. (A) His-tagged recombinant PpPIPK1 proteins. A repetition of eight MORN motifs (grey boxes) and the conserved catalytic domain (black box) are indicated in wild type and mutant PpPIPK1s. The MORN repeat and junction of internal deletion are indicated by amino acid position numbers. (B) In vitro lipid kinase activity of His-tagged recombinant proteins. The activities of recombinant proteins bound to Ni-NTA agarose beads were assayed with PtdIns4P. (C) In vitro PA-dependent lipid kinase activity of His-tagged proteins. The activities of recombinant proteins bound to Ni-NTA agarose beads were assayed with PtdIns4P with 143 µM PA. Top and bottom arrowheads represent reaction products PtdIns(4,5)P₂ and lysoPtdIns(4,5)P₂, respectively.Biochemical analyses of these enzymes after expression in yeast P. pastoris X-33 cells followed by purification showed that deletion of the N-terminal region (PpPIPK1ΔN) reduced PpPIPK1 activity ca 40% compared to the full length enzyme, whereas loss of the MORN repeat (PpPIPK1ΔMORN) had no significant effect (Fig. 1B). In agreement, a mutant lacking four MORN repeats of the total eight repeats showed no difference in the activity compared the full length enzyme (data not shown). These results indicate a positive role of the N-terminal region, but not the MORN repeats, on PpPIPK1 activity. However, these findings differ from those obtained with AtPIP5K1, where the MORN domain represses enzymatic activity.¹⁵ Interestingly, PpPIPK1ΔN-MORN containing the linker and catalytic regions showed higher enzymatic activity of ca 23 % compared to the full length PpPIPK1 (Fig. 1B). The C-terminal half only containing the catalytic domain of PpPIPK1 and thus lacking the linker region showed a reduced activity.²² It is therefore proposed that the linker region carries a positive regulatory element. Although details are unknown, negligible effects of the N-terminal and MORN domains for the enzymatic activity has been indicated in AtPIP5K3 from A. thaliana.¹¹ Moreover, it is noteworthy that PA-dependent activation was not affected by any deletion as shown in Figure 1C, confirming that the N-terminal half is not involved in PA dependency of the PpPIPK1 activity.²²Our results indicated that the MORN domain is not involved in the regulation of the catalytic activity in PpPIPK1. Similarly, the function of the MORN domain found in the accumulation and replication of chloroplasts 3 (ARC3) was not resolved. ARC3 is an FtsZ homologue involved in chloroplast division²⁴ and the only protein containing the MORN repeats other than PIPKs in A. thaliana. It was shown that the ARC3 MORN domain did not interact with any stromal plastid division components.²⁵ Moreover, there are reports representing functions of the MORN domain other than plasma membrane binding. Human amyotrophic lateral sclerosis 2 (ALS2), a guanine nucleotide exchange factor (GEF) specific to the small GTPase Rab5, contains the MORN domain at the central region that is essential for the GEF activity but not for interaction with Rab5.²⁶ In contrast, specific interaction of the MORN domain with Rab-E GTPases and resultant enzymatic activation was recently demonstrated for AtPIP5K2.¹² It is interesting that these results are inconsistent with each other in terms of interaction of the MORN domain with small GTPases.Taken together, with no function of the MORN domain in plasma membrane localization of PpPIPK1 and AtPIP5K1,²² the function of the MORN domain is still unknown, despite its high conservation plants PIPKs. Alternatively, based on the findings of ARC3, ALS2 and AtPIP5K2,^12,25,26 the function of the MORN domain possibly varies among PIPK isoforms and may thus have multifunctional roles. Therefore, it is necessary to identify interaction partners for the MORN domain of each plant PIPKs and to analyze phenotypes of transgenic plants carrying MORN domain-lacking PIPKs during developmental process and environmental stress responses.     

Structural basis of transmembrane domain interactions in integrin signaling

Cell surface receptors of the integrin family are pivotal to cell adhesion and migration. The activation state of heterodimeric αβ integrins is correlated to the association state of the single-pass α and β transmembrane domains. The association of integrin αIIbβ3 transmembrane domains, resulting in an inactive receptor, is characterized by the asymmetric arrangement of a straight (αIIb) and tilted (β3) helix relative to the membrane in congruence to the dissociated structures. This allows for a continuous association interface centered on helix-helix glycine-packing and an unusual αIIb(GFF) structural motif that packs the conserved Phe-Phe residues against the β3 transmembrane helix, enabling αIIb(D723)β3(R995) electrostatic interactions. The transmembrane complex is further stabilized by the inactive ectodomain, thereby coupling its association state to the ectodomain conformation. In combination with recently determined structures of an inactive integrin ectodomain and an activating talin/β complex that overlap with the αβ transmembrane complex, a comprehensive picture of integrin bi-directional transmembrane signaling has emerged.Key words: cell adhesion, membrane protein, integrin, platelet, transmembrane complex, transmembrane signalingThe communication of biological signals across the plasma membrane is fundamental to cellular function. The ubiquitous family of integrin adhesion receptors exhibits the unusual ability to convey signals bi-directionally (outside-in and inside-out signaling), thereby controlling cell adhesion, migration and differentiation.^1–5 Integrins are Type I heterodimeric receptors that consist of large extracellular domains (>700 residues), single-pass transmembrane (TM) domains, and mostly short cytosolic tails (<70 residues). The activation state of heterodimeric integrins is correlated to the association state of the TM domains of their α and β subunits.^6–10 TM dissociation initiated from the outside results in the transmittal of a signal into the cell, whereas dissociation originating on the inside results in activation of the integrin to bind ligands such as extracellular matrix proteins. The elucidation of the role of the TM domains in integrin-mediated adhesion and signaling has been the subject of extensive research efforts, perhaps commencing with the demonstration that the highly conserved GFFKR sequence motif of α subunits (Fig. 1), which closely follows the first charged residue on the intracellular face, αIIb(K989), constrains the receptor to a default low affinity state.¹¹ Despite these efforts, an understanding of this sequence motif had not been reached until such time as the structure of the αIIb TM segment was determined.¹² In combination with the structure of the β3 TM segment¹³ and available mutagenesis data,^6,9,10,14,15 this has allowed the first correct prediction of the overall association of an integrin αβ TM complex.¹² The predicted association was subsequently confirmed by the αIIbβ3 complex structure determined in phospholipid bicelles,¹⁶ as well as by the report of a similar structure based on molecular modeling using disulfide-based structural constraints.¹⁷ In addition to the structures of the dissociated and associated αβ TM domains, their membrane embedding was defined^{12,13,16,18,19} and it was experimentally recognized that, in the context of the native receptor, the TM complex is stabilized by the inactive, resting ectodomain.¹⁶ These advances in integrin membrane structural biology are complemented by the recent structures of a resting integrin ectodomain and an activating talin/β cytosolic tail complex that overlap with the αβ TM complex,^20,21 allowing detailed insight into integrin bi-directional TM signaling.Open in a separate windowFigure 1Amino acid sequence of integrin αIIb and β3 transmembrane segments and flanking regions. Membrane-embedded residues^{12,13,16,18,19} are enclosed by a gray box. Residues 991–995 constitute the highly conserved GFFKR sequence motif of integrin α subunits.     

Keratinocyte-Targeted Expression of Human Laminin γ2 Rescues Skin Blistering and Early Lethality of Laminin γ2 Deficient Mice

Laminin-332 is a heterotrimeric basement membrane component comprised of the α3, ß3, and γ2 laminin chains. Laminin-332 modulates epithelial cell processes, such as adhesion, migration, and differentiation and is prominent in many embryonic and adult tissues. In skin, laminin-332 is secreted by keratinocytes and is a key component of hemidesmosomes connecting the keratinocytes to the underlying dermis. In mice, lack of expression of any of the three Laminin-332 chains result in impaired anchorage and detachment of the epidermis, similar to that seen in human junctional epidermolysis bullosa, and death occurs within a few days after birth. To bypass the early lethality of laminin-332 deficiency caused by the knockout of the mouse laminin γ2 chain, we expressed a dox-controllable human laminin γ2 transgene under a keratinocyte-specific promoter on the laminin γ2 (Lamc2) knockout background. These mice appear similar to their wild-type littermates, do not develop skin blisters, are fertile, and survive >1.5 years. Immunofluorescence analyses of the skin showed that human laminin γ2 colocalized with mouse laminin α3 and ß3 in the basement membrane zone underlying the epidermis. Furthermore, the presence of “humanized” laminin-332 in the epidermal basement membrane zone rescued the alterations in the deposition of hemidesmosomal components, such as plectin, collagen type XVII/BP180, and integrin α6 and ß4 chains, seen in conventional Lamc2 knockout mice, leading to restored formation of hemidesmosomes. These mice will be a valuable tool for studies of organs deficient in laminin-332 and the role of laminin-332 in skin, including wound healing.     

Immunotherapy for Alzheimer disease

Immunotherapy approaches for Alzheimer disease currently are among the leading therapeutic directions for the disease. Active and passive immunotherapy against the β-amyloid peptides that aggregate and accumulate in the brain of those afflicted by the disease have been shown by numerous groups to reduce plaque pathology and improve behavior in transgenic mouse models of the disease. Several ongoing immunotherapy clinical trials for Alzheimer disease are in progress. The background and ongoing challenges for these immunological approaches for the treatment of Alzheimer disease are discussed.Key words: Alzheimer disease, amyloid, tau, immunotherapy, vaccineThe publication in Nature on a vaccine approach for Alzheimer disease (AD) by Schenk and colleagues in 1999 initiated a push for treatment for this major disease of aging. AD neuropathology is characterized by the progressive loss of synapses and neurons, and the aberrant accumulation in the brain of β-amyloid peptides in plaques and the microtubule associated protein tau in neurofibrillary tangles. Mutations in familial forms of AD have been associated with elevated β-amyloid levels, whereas mutations in tau have been linked to familial forms of frontotemporal dementia. Remarkably, injection of β-amyloid peptides with Freund''s adjuvant into transgenic mice harboring a human AD mutation that develop AD-like neuropathology and progressive cognitive decline led to reduced β-amyloid plaque pathology.¹ This study was subsequently confirmed and extended by multiple groups to show also behavioral improvement in AD transgenic mice with active β-amyloid immunization.^2,3 Passive immunotherapy with antibodies directed at β-amyloid were similarly effective in reducing plaques and improving behavior in AD transgenic mice.⁴ A temporary setback occurred when the first clinical trial with β-amyloid vaccination was halted after 6% of patients developed an inflammatory reaction in the brain (chemical meningoencephalitis). A subsequent study supported clinical benefits among patients in this active vaccination trial.⁵ A more recent postmortem study on a subset of patients who had participated in the aborted trial supported active removal of β-amyloid plaques by inflammatory cells, but also indicated that 7 of the 8 patients who were studied at autopsy continued to have progressive cognitive decline despite the removal of amyloid plaques.⁶The critical mechanisms whereby active or passive vaccination against β-amyloid can affect the disease process remain uncertain. Recruitment and activation of microglia, the macrophage of the central nervous system, by β-amyloid antibodies is thought to lead to β-amyloid plaque removal. At the same time, fibrillar β-amyloid containing plaques, formerly viewed as the major toxic entities in AD, are increasingly viewed as potentially only pathological remnants of the disease. Smaller assemblies, particularly of two to twelve β-amyloid peptides (oligomers), are considered pathogenic, although the site of pathogenesis remains controversial. Secreted, extracellular β-amyloid oligomers have been shown to damage synapses.⁷ Some groups stress the aberrant accumulation of β-amyloid within neurons and synapses leading to subsequent extracellular localization following destruction of neurites and synapses.⁸ Evidence has been presented that antibodies targeting β-amyloid peptides up to 42–43 amino acids can block the toxic effects of extracellular β-amyloid oligomers on synapses.⁷ Interestingly, β-amyloid immunotherapy was also shown to clear intraneuronal β-amyloid in an AD transgenic mouse; the intraneuronal variety is a pool of β-amyloid that correlates with the onset of cognitive decline prior to plaques and tangles in these mice.⁹ Intriguingly, antibodies directed at the β-amyloid domain exposed to the extracellular space within the amyloid precursor protein (APP) were shown to be internalized by neurons, where they reduced the intraneuronal pool of β-amyloid and protected against synaptic damage in neurons cultured from AD transgenic mice.^10,11 It is possible that inefficient clearance of the intracellular pool of β-amyloid played a role in the continued cognitive decline in the seven of eight patients in the aborted active vaccination clinical trial studied at autopsy who showed clearance of β-amyloid plaques.Work on β-amyloid immunotherapy in AD contributed to a reevaluation of the role of the immune system in the brain. Previously, it was considered that the brain was immune privileged, and that antibodies entered the brain only with the breakdown of the blood brain barrier. Rare neuroimmunological disorders had suggested more complex interactions. Pathological antibodies directed at neuronal proteins could be found localizing to specific types of neurons in paraneoplastic diseases linked to diverse systemic cancers^12,13 or collagen-vascular diseases such as lupus.¹⁴ Such pathological antibodies can be directed at synaptic or even intracellular proteins in selective neurons in the brain, leading to localized neurological symptoms. For paraneoplastic diseases it is hypothesized that antibodies directed at the cancer cells cross-react with neuronal antigens. Since titers of antibodies can be higher in brain than in the blood, intrathecal synthesis of antibodies from sequestration of B cells has been proposed to occur in the brain.¹⁵ The interaction between the immune system and the brain is therefore viewed as increasingly complex, with antibodies not only gaining access to the brain but also nerve cells, where they can even alter intracellular biology.¹⁰ These findings open up new possibilities for antibody-directed therapies for diseases of the nervous system.Currently, leading concerns for β-amyloid immunotherapy are the potential development of chemical meningoencephalitis and micro-hemorrhages in the brain. Involvement of T cells in damage to the brain vasculature is considered to contribute to these potential side effects. In addition, the β-amyloid released upon antibody-induced removal of plaques may damage blood vessels as β-amyloid is cleared from the brain via the vasculature.¹⁶ Recently, a phase 2 Elan/Wyeth study using passive β-amyloid immunotherapy with a humanized monoclonal antibody described (at the 2008 International Conference on Alzheimer''s disease) significant benefits in patients not harboring the apolipoprotein E4 (apoE4) allele genetic risk factor for late onset AD. In contrast, no clear therapeutic benefit and more cases with brain inflammation occurred in those with the apoE4 allele linked with an increased risk for AD. Why apoE4 carriers did not benefit in this β-amyloid immunotherapy trial is unknown, but has prompted separation of patients into E4 negative and positive groups in subsequent clinical trials. The less robust than hoped for effects even in the apoE4 negative patients has further dampened expectations. The reason for why the human studies are not showing the protection seen in the transgenic mouse studies could relate to β-amyloid playing less of a role in the more typical late onset AD than it does in the rare autosomal dominant familial forms used to generate the AD transgenic mice. It is also not clear which β-amyloid epitope(s) should be targeted by antibodies to maximize potential benefits while minimizing side effects in AD patients. Optimizing antibody specificity for immunotherapy is further complicating by the varied conformations of different β-amyloid aggregation states. In addition, β-amyloid immunotherapy may be more challenging in patients with AD because it is not effective in reducing tau tangle pathology.⁶ Most immunotherapy studies were done on transgenic AD mouse models that deposit β-amyloid plaques, but not tau tangles. In the more recently generated triple transgenic AD mouse that develops both plaques and tangles, β-amyloid antibodies reversed β-amyloid pathology and early pre-tangle tau pathology, but not hyperphosphorylated tau aggregates.⁸ Recent evidence supports that β-amyloid neurotoxicity acts synergistic with tau,¹⁷ and that both pathologies begin at synapses.¹⁸ Interestingly, tau immunotherapy was reported to protect against tau pathology in transgenic mice harboring mutant tau.¹⁹ Thus, dual immunotherapy targeting of both β-amyloid and tau can be considered. Finally, immunotherapy at earlier stages of the disease process may be more effective.In summary, the β-amyloid vaccine heralded a new era of therapeutic research for AD and despite some setbacks is actively being pursued in several ongoing clinical trials. It continues to be among the leading hopes in the AD research community. Another major effort to specifically block the generation of β-amyloid is also progressing, although not without setbacks along the way. For example, the protease involved in the final cleavage to liberate β-amyloid was found to be involved in multiple other important activities, such as cleavage of Notch. Antibody approaches are also being applied in efforts to block secretase cleavage to generate β-amyloid.²⁰ Finally, there remains some worry that β-amyloid peptides have an as yet unknown normal biological function, although cumulative immunotherapy and other therapeutic studies in animal models have provided sufficient support for the continued pursuit of β-amyloid lowering as a treatment for AD.     

Osh6 links yeast vacuolar functions to lifespan extension and TOR

Comment on: Gebre S, et al. Cell Cycle 2012; 11:2176-88.Almost all organisms age–the aging process is both genetically determined and can be modified by the environment. Lifespan extension by dietary restriction (DR) is observed in evolutionarily distant species from yeast to mammals. Not only are the phenomena of aging and DR conserved, but at least some mechanisms and genes are evolutionarily conserved, which may pave the way to manipulate human aging.¹ For example, TOR (target of rapamycin) mediates aging and, when suppressed, triggers anti-aging processes in many species. Moreover, identifying genes that modulate the potential for cell division is of great interest, given that changes in the number of times that cells divide have been associated with longevity manipulations in mammals (including DR).²Sterols are hydrophobic molecules present in all cellular organisms. For instance, cholesterol is an essential structural component of cellular membranes of mammals and several of its derivates have additional hormonal and signaling functions. Oxysterols are oxygenated derivates of cholesterol. Oxysterol-binding protein (OSBP)-related protein (ORP) family members are present in numerous copies from yeast to man, suggesting that this protein family has fundamental functions in eukaryotes. OSBP and ORPs regulate lipid metabolism, vesicle transport and various signaling pathways³ and may specifically mediate lipid exchange at membrane contact sites.The lifespan-extending effect of DR has often been shown to be mediated by specific genes and to be accompanied by discrete changes in gene expression as well as metabolic reprogramming. Both lipid metabolism and cellular recycling activities have been demonstrated to be essential for lifespan extension in numerous species. For example, DR suppresses sterol synthesis from yeast to mammals,⁴ while it induces some form of autophagy, a mighty housekeeping mechanism utilizing lysosomes within its power to recycle various kinds of molecules and cellular structures. Vacuoles, the yeast equivalent of mammalian lysosomes, are highly dynamic organelles that fuse and divide in response to environmental or intrinsic cues. Mutants with defects in vacuolar fusion (such as ypt7Δ, nyv1Δ, vac8Δ, or erg6Δ) are either short-lived or do not appear to respond to DR.⁵While mammals have 12 OSBPs, the yeast genome encodes seven oxysterol-binding protein sequence homologs (OSH). Deletion of any OSH gene alone does not impact on vacuolar morphology, yet deletion of all results in highly fragmented vacuoles, a sign of defective vacuole fusion. Gebre et al. now show that overexpression of OSH family member OSH6 in yeast can complement the vacuole fusion defect of nyv1Δ but not erg6Δ or vac8Δ. Thus, Osh6 mediates vacuolar fusion, which depends on ergosterol (Erg6), and the protein anchor Vac8. In contrast, overexpression of another OSH-family member, OSH5, exacerbated fragmentation and decreased lifespan in wild-type cells. It is interesting to note that OSH5 expression progressively increases with age, and Osh6 overexpression blocked this age-dependent change in OSH5 levels. Also, elevated Osh6 maintains the enrichment of Vac8 in microdomains of vacuolar membranes with advancing age, which is required for vacuole fusion. Intriguingly, exactly at the age when the longevity protein Sir2 declines, Osh6 protein levels also decline.⁶Furthermore, Gebre et al. showed that P_ERG6-OSH6 (ERG6 promoter driving OSH6 overexpression) dramatically extends the lifespan of wild-type and nyv1Δ mutants. tor1Δ mutants are also long-lived, though not so long as P_ERG6-OSH6. Surprisingly, P_ERG6-OSH6 tor1Δ double mutant had a very short lifespan. P_ERG6-OSH6 mutants were more sensitive to TOR inhibitors, indicating that TOR is less active in this strain.⁶ OSH6 overexpression downregulates total cellular sterol levels, just like DR. Osh6 binds PI3P and PI(3,5)P2 which are vacuole-specific lipids.⁷ As such, Osh6 might promote vacuole fusion by regulating the transports and/or distribution of sterols to the vacuolar membranes. But where are the sterols coming from? Numerous overexpression mutants with effects in vacuolar morphology are involved in endocytosis.⁸ Similarly, Osh6’s coiled-coil domain interacts with Vps4, which is located in endosomes. TOR complex 1 (TORC1) also sits on endosomes as well as on vacuoles and actively catalyzes vacuolar scission.⁹ Osh6 may therefore (1) transport sterols from late endosomes to the vacuolar membrane (Fig. 1), which increases the homototypic fusion ability of vacuoles, and (2) averaging the lipids between late endosome and vacuoles promotes also late-endosome-to-vacuole fusion.Open in a separate windowFigure 1. Putative mechanism of the lifespan extension conferred by Osh6 overexpression. TORC1 promotes vacuolar scission and therefore fragments vacuoles. In contrast, Osh6 enhances vacuolar fusion and might be doing this by transporting sterols from the endosomes to the vacuolar membrane. Improved vacuolar morphology then promotes autophagy. Thus, Osh6 appears to counteract TORC1 activity.Overall, Gebre and colleagues link the vacuole to lifespan extension, perhaps via TOR, and reveal that vacuole fusion is both necessary and sufficient for lifespan extension.     

Integrin switching modulates adhesion dynamics and cell migration

When cells are stimulated to move, for instance during development, wound healing or angiogenesis, they undergo changes in the turnover of their cell-matrix adhesions. This is often accompanied by alterations in the expression profile of integrins—the extracellular matrix receptors that mediate anchorage within these adhesions. Here, we discuss how a shift in expression between two different types of integrins that bind fibronectin can have dramatic consequences for cell-matrix adhesion dynamics and cell motility.Key words: integrin, fibronectin, migration, cytoskeleton, dynamicsCells attach to the extracellular matrix (ECM) that surrounds them in specialized structures termed “cell-matrix adhesions.” These come in different flavors including “focal complexes” (small adhesions found in membrane protrusions of spreading and migrating cells), “focal adhesions” (larger adhesions connected by F-actin stress fibers that are derived from focal complexes in response to tension), “fibrillar adhesions” (elongated adhesions associated with fibronectin matrix assembly), and proteolytically active adhesions termed “podosomes” or “invadopodia” found in osteoclasts, macrophages and certain cancer cells. Common to all these structures is the local connection between ECM proteins outside- and the actin cytoskeleton within the cell through integrin transmembrane receptors. The intracellular linkage to filamentous actin is indirect through proteins that concentrate in cell-matrix adhesions such as talin, vinculin, tensin, parvins and others.¹Cell migration is essential for embryonic development and a number of processes in the adult, including immune cell homing, wound healing, angiogenesis and cancer metastasis. In moving cells, cell-matrix adhesion turnover is spatiotemporally controlled.² New adhesions are made in the front and disassembled in the rear of cells that move along a gradient of motogenic factors or ECM proteins. This balance between formation and breakdown of cell-matrix adhesions is important for optimal cell migration. Several mechanisms regulate the turnover of cell-matrix adhesions. Proteolytic cleavage of talin has been identified as an important step in cell-matrix adhesion disassembly³ and FAK and Src family kinases are required for cell-matrix adhesion turnover and efficient cell migration.^4,5 Besides regulating phospho-tyrosine-mediated protein-protein interactions within cell-matrix adhesions, the FAK/Src complex mediates signaling downstream of integrins to Rho GTPases, thus controlling cytoskeletal organization.^6,7 The transition from a stationary to a motile state could involve (local) activation of such mechanisms.Interestingly, conditions of increased cell migration (development, wound healing, angiogenesis, cancer metastasis) are accompanied by shifts in integrin expression with certain integrins being lost and others gained. Most ECM proteins can be recognized by various different integrins. For instance, the ECM protein, fibronectin (Fn) can be recognized by nine different types of integrins and most of these bind to the Arg-Gly-Asp (RGD) motif in the central cell-binding domain. Thus, cell-matrix adhesions formed on Fn contain a mixture of different integrins and shifts in expression from one class of Fn-binding integrins to another will alter the receptor composition of such adhesions. This may provide an alternative means to shift from stationary to motile.Indeed, we have found that the type of integrins used for binding to Fn strongly affects cell migration. We made use of cells deficient in certain Fn-binding integrins and either restored their expression or compensated for their absence by overexpression of alternative Fn-binding integrins. This allowed us to compare in a single cellular background cell-matrix adhesions containing α5β1 to those containing αvβ3. Despite the fact that these integrins support similar levels of adhesion to Fn, only α5β1 was found to promote a contractile, fibroblastic morphology with centripetal orientation of cell-matrix adhesions⁸ (Fig. 1). Moreover, RhoA activity is high in the presence of α5β1 and these cells move in a random fashion with a speed of around 25 mm/h. By contrast, in cells using αvβ3 instead, adhesions distribute across the ventral surface, RhoA activity is low, and these cells move with similar speed but in a highly persistent fashion.^8,9 Finally, photobleaching experiments using GFP-vinculin and GFP-paxillin demonstrated that cell-matrix adhesions containing α5β1 are highly dynamic whereas adhesions containing αvβ3 are more static.⁹Open in a separate windowFigure 1Immunofluorescence images. GE11 cells, epithelial β1 knockout cells derived from mouse embryos chimeric for the integrin β1 subunit endogenously express various av integrins, including low levels of αvβ3 and αvβ5. Ectopic expression of β1 leads to expression of α5β1 and induced α5β1-mediated adhesion to Fn (left image) whereas ectopic expression of β3 (in the β1 null background) leads to strong expression of αvβ3 and induced αvβ3-mediated adhesion to Fn (right image). Adhesions containing either α5β1 or αvβ3 show distinct distribution and dynamics (paxillin; green) and cause different F-actin organization (phalloidin; red). Cartoons: Differences in cell-matrix adhesion dynamics may be explained by differential binding of soluble Fn molecules (blue) or different molecular determinants of the interaction with immobilized Fn (red). See text for details.It has been observed that α5β1 and αvβ3 use different recycling routes. Interfering with Rab4-mediated recycling of αvβ3 causes increased Rab11-mediated recycling of α5β1 to the cell surface. In agreement with our findings, the shift to α5β1 leads to increased Rho-ROCK activity and reduced persistence of migration.¹⁰ One possible explanation for the different types of migration promoted by these two Fn-binding integrins might involve different signaling and/or adaptor proteins interacting with specific amino acids in their cytoplasmic tails. However, this appears not to be the case: α5β1 in which the cytoplasmic tails of α5 or β1 are replaced by those of αv or β3, respectively, behaves identical to wild type α5β1: it promotes a fibroblast-like morphology with centripetal orientation of cell-matrix adhesions and it drives a non-persistent mode of migration.^8,11 Together, these findings point to differences between α5β1 and αvβ3 integrins in the mechanics of their interaction with Fn, which apparently modulates intracellular signaling pathways in control of cell-matrix adhesion dynamics and cell migration.How might this work? It turns out that although α5β1 and αvβ3 similarly support cell adhesion to immobilized (stretched) Fn, only α5β1 efficiently binds soluble, folded (“inactive”) Fn.¹¹ We have proposed that such interactions with soluble Fn molecules (possibly secreted by the cell itself) may weaken the interaction with the immobilized ligand thereby causing enhanced cell-matrix adhesion dynamics in the presence of α5β1,¹¹ (Fig. 1). Preferential binding of soluble Fn by α5β1 could be explained by differences in accessibility of the RGD binding pocket between α5β1 (more exposed) and αvβ3 (more hidden) as suggested by others.¹² If this is the case, immobilization (“stretching”) of Fn apparently leads to reorientation of the RGD motif in such a way that it is easily accessed by both integrins.The issue is considerably complicated by the fact that other recognition motifs are present in the Fn central cell-binding domain. In addition to the RGD sequence in the tenth Fn type 3 repeat (IIIFn10), binding of α5β1, but not αvβ3, also depends on the PHSRN “synergy” sequence in IIIFn9.^13–15 The relative contribution of these motifs is controversial and there is structural data pointing either towards a model in which IIIFn9 interacts with α5β1 or towards a model in which IIIFn9 exerts long-range electrostatic steering resulting in a higher affinity interaction without contacting the integrin.^16,17 Cell adhesion studies have suggested that an interaction of α5β1 with the synergy region stabilizes the binding to RGD.^14,18 Such a two-step interaction may facilitate binding to full length, folded Fn for instance by altering the tilt angle between IIIFn9 and IIIFn10 leading to optimal exposure of the RGD loop, perhaps explaining why αvβ3 (which may not interact with the synergy site) poorly binds soluble Fn.Others have shown that the RGD motif alone is sufficient for mechanical coupling of αvβ3 to Fn whereas the synergy region is required to provide mechanical strength to the α5β1-Fn bond.¹⁹ It appears that the interaction of α5β1 with Fn is particularly dynamic with various conformations of α5β1 interacting with different Fn binding surfaces, including the RGD and synergy sequences as well as other regions in IIIFn9. Thus, besides the above model based on differential binding to soluble Fn molecules, differences in the complexity and dynamics of interactions with immobilized Fn that determine functional binding strength could also underlie the different dynamics of cell-matrix adhesions containing either α5β1 or αvβ3 (Fig. 1).Precisely how mechanical differences in receptor-ligand interactions result in such remarkably distinct cellular responses is poorly understood. In addition to effects on cell-matrix adhesion dynamics and cytoskeletal organization it is also associated with different activities of Rho GTPases, indicating that mechanical differences between these two integrins must translate into differential activation of intracellular signaling pathways.^8,9,11 Possibly, different adhesion dynamics due to distinct mechanisms of receptor-ligand interaction result in different patterns of F-actin organization, which, in turn, affects the formation of signaling platforms. It is also possible that differences in the extent of integrin clustering have an impact on the conformation of one or more cytoplasmic components of the cell-matrix adhesions containing either α5β1 or αvβ3. This could lead to hiding or exposing binding sites for signaling molecules (e.g., upstream regulators of Rho GTPases) or substrates. Whatever the mechanism involved, altering the integrin composition of cell-matrix adhesions through shifts in integrin expression as observed during development, angiogenesis, wound healing and cancer progression may be a driving force in the enhanced cell migration that characterizes those processes.